Features & Compatibility
This research blend combines BPC-157 and TB-500, two peptides investigated in laboratory models involving cellular repair and tissue-response mechanisms.
BPC-157 is primarily studied for its interaction with fibroblast activity, cell migration and soft-tissue-repair pathways. TB-500 is associated with thymosin beta-4 research and is investigated for its role in actin regulation, angiogenesis, cell migration and extracellular-matrix organization. Together, the blend provides a useful reference for studying complementary repair-related signaling pathways.
Variants:
10mg10vials | 20mg10vials | 40mg*10vials
For laboratory research use only. Not intended for human consumption or therapeutic use.
Customer Reviews
Related Products
Eloralintide
Eloralintide, formerly known as LY3841136, is an investigational, long-acting and selective amylin receptor agonist. It is designed to mimic amylin,
GHK-CU
GHK-Cu is a naturally occurring copper-binding tripeptide composed of Glycine, Histidine and Lysine complexed with copper ions. It is studied
Glow
Glow is a three-component research peptide blend combining BPC-157, GHK-Cu and TB-500. The formula is designed for laboratory studies involving
Ipamorelin
Ipamorelin is a synthetic peptide and selective growth hormone secretagogue receptor (GHS-R) agonist. It is studied for its ability to
TB500(Thymosin B4 Acetate)
TB-500 is a synthetic research peptide related to Thymosin Beta-4, a naturally occurring actin-binding peptide involved in cellular organization and
Tirzepatide
Tirzepatide is a modified peptide that acts as a dual agonist of the GIP and GLP-1 receptors. Its dual-receptor profile

Reviews
There are no reviews yet.